The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures
Launched by CITY OF HOPE MEDICAL CENTER · Jan 3, 2023
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a special robotic device called the da Vinci single port (SP1098) for surgeries in the abdomen and pelvis. The goal is to see if this device can make surgeries less invasive, which means that doctors can perform them through just one small cut instead of larger openings. This could lead to less pain, fewer complications, and a quicker recovery for patients after surgery.
To participate in this trial, you need to be at least 18 years old and scheduled for a robot-assisted abdominal or pelvic surgery. However, if your body mass index (BMI) is over 45, or if you have certain health issues that would make minimally invasive surgery unsafe, you may not be eligible. If you join the trial, you can expect to receive care using this new robotic technology while helping researchers learn more about its effectiveness and safety. The trial is currently looking for participants, so it’s an opportunity to be part of advancing surgical techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Documented informed consent of the participant and/or legally authorized representative
- • Any patient scheduled to undergo robot-assisted abdominal or pelvic procedures
- • Age \> 18 years
- Exclusion Criteria:
- • Body mass index (BMI) \> 45
- • Contraindications to minimally invasive surgery including chronic obstructive pulmonary disorders
- • Past history of failed attempt of minimally invasive abdominal or pelvic surgery
About City Of Hope Medical Center
City of Hope Medical Center is a leading research and treatment institution located in Duarte, California, dedicated to advancing innovative therapies and improving patient outcomes in the fields of cancer, diabetes, and other life-threatening diseases. With a strong emphasis on translational medicine, City of Hope combines cutting-edge research with compassionate care, fostering a collaborative environment for clinical trials that aim to bring new treatments from the laboratory to the bedside. The center is recognized for its commitment to patient-centered care and its role as a National Cancer Institute-designated Comprehensive Cancer Center, making it a pivotal player in the landscape of medical research and clinical innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Duarte, California, United States
Patients applied
Trial Officials
Mehdi Moslemi-Kebria
Principal Investigator
City of Hope Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials